Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characteristics and risk factors for poor outcome in patients with systemic vasculitis involving the gastrointestinal tract.
Gendreau S, Porcher R, Thoreau B, Paule R, Maurier F, Goulenok T, Frumholtz L, Bernigaud C, Ingen-Housz-Oro S, Mekinian A, Audemard-Verger A, Gaillet A, Perard L, Samson M, Sonneville R, Arlet JB, Mirouse A, Kahn JE, Charpentier J, Hachulla É, Hummel A, Pires T, Carron PL, Durel CA, Jourde W, Puechal X, Lega JC, Sarrot-Reynauld F, Tieulie N, Diot E, Guillevin L, Terrier B; French Vasculitis Study Group. Gendreau S, et al. Among authors: perard l. Semin Arthritis Rheum. 2021 Apr;51(2):436-441. doi: 10.1016/j.semarthrit.2021.03.002. Epub 2021 Mar 3. Semin Arthritis Rheum. 2021. PMID: 33711774
Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients.
Terrier B, Saadoun D, Sène D, Sellam J, Pérard L, Coppéré B, Karras A, Blanc F, Buchler M, Plaisier E, Ghillani P, Rosenzwajg M, Cacoub P. Terrier B, et al. Among authors: perard l. Arthritis Rheum. 2009 Aug;60(8):2531-40. doi: 10.1002/art.24703. Arthritis Rheum. 2009. PMID: 19644879 Free article. Clinical Trial.
Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.
Jallouli M, Francès C, Piette JC, Huong du LT, Moguelet P, Factor C, Zahr N, Miyara M, Saadoun D, Mathian A, Haroche J, De Gennes C, Leroux G, Chapelon C, Wechsler B, Cacoub P, Amoura Z, Costedoat-Chalumeau N; Plaquenil LUpus Systemic Study Group. Jallouli M, et al. JAMA Dermatol. 2013 Aug;149(8):935-40. doi: 10.1001/jamadermatol.2013.709. JAMA Dermatol. 2013. PMID: 23824340
Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide.
Morel N, Bachelot A, Chakhtoura Z, Ghillani-Dalbin P, Amoura Z, Galicier L, Aumaitre O, Piette JC, Pourrat J, Boutin D, Sacre K, Kahn JE, Duhaut P, Farge D, Francès C, Guettrot-Imbert G, Harlé JR, Lambotte O, Le Guern V, Sène D, Trad S, Vidal E, Sarrot-Reynauld F, Gompel A, Tanguy ML, Touraine P, Lacorte JM, Costedoat-Chalumeau N; PLUS group. Morel N, et al. J Clin Endocrinol Metab. 2013 Sep;98(9):3785-92. doi: 10.1210/jc.2013-1235. Epub 2013 Jul 5. J Clin Endocrinol Metab. 2013. PMID: 23833039 Clinical Trial.
Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy.
Pagnoux C, Quéméneur T, Ninet J, Diot E, Kyndt X, de Wazières B, Reny JL, Puéchal X, le Berruyer PY, Lidove O, Vanhille P, Godmer P, Fain O, Blockmans D, Bienvenu B, Rollot F, Aït el Ghaz-Poignant S, Mahr A, Cohen P, Mouthon L, Perrodeau E, Ravaud P, Guillevin L; French Vasculitis Study Group. Pagnoux C, et al. Arthritis Rheumatol. 2015 Apr;67(4):1117-27. doi: 10.1002/art.39011. Arthritis Rheumatol. 2015. PMID: 25693055 Clinical Trial.
Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature.
De Parisot A, Puéchal X, Langrand C, Raverot G, Gil H, Perard L, Le Guenno G, Berthier S, Tschirret O, Eschard JP, Vinzio S, Guillevin L, Sève P; and the French Vasculitis Study Group. De Parisot A, et al. Among authors: perard l. Medicine (Baltimore). 2015 Apr;94(16):e748. doi: 10.1097/MD.0000000000000748. Medicine (Baltimore). 2015. PMID: 25906106 Free PMC article.
Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients.
Durel CA, Marignier R, Maucort-Boulch D, Iwaz J, Berthoux E, Ruivard M, André M, Le Guenno G, Pérard L, Dufour JF, Turcu A, Antoine JC, Camdessanche JP, Delboy T, Sève P. Durel CA, et al. Among authors: perard l. J Neurol. 2016 May;263(5):981-990. doi: 10.1007/s00415-016-8092-5. Epub 2016 Mar 23. J Neurol. 2016. PMID: 27007482
Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network.
Vallet H, Seve P, Biard L, Baptiste Fraison J, Bielefeld P, Perard L, Bienvenu B, Abad S, Rigolet A, Deroux A, Sene D, Perlat A, Marie I, Feurer E, Hachulla E, Fain O, Clavel G, Riviere S, Bouche PA, Gueudry J, Pugnet G, Le Hoang P, Resche Rigon M, Cacoub P, Bodaghi B, Saadoun D; French Uveitis Network. Vallet H, et al. Among authors: perard l. Arthritis Rheumatol. 2016 Jun;68(6):1522-30. doi: 10.1002/art.39667. Arthritis Rheumatol. 2016. PMID: 27015607 Free article.
Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients.
Jamilloux Y, Cohen-Aubart F, Chapelon-Abric C, Maucort-Boulch D, Marquet A, Pérard L, Bouillet L, Deroux A, Abad S, Bielefeld P, Bouvry D, André M, Noel N, Bienvenu B, Proux A, Vukusic S, Bodaghi B, Sarrot-Reynauld F, Iwaz J, Amoura Z, Broussolle C, Cacoub P, Saadoun D, Valeyre D, Sève P; Groupe Sarcoïdose Francophone. Jamilloux Y, et al. Among authors: perard l. Semin Arthritis Rheum. 2017 Oct;47(2):288-294. doi: 10.1016/j.semarthrit.2017.03.005. Epub 2017 Mar 8. Semin Arthritis Rheum. 2017. PMID: 28392046
Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients.
Desbois AC, Biard L, Addimanda O, Lambert M, Hachulla E, Launay D, Ackermann F, Pérard L, Hot A, Maurier F, Mausservey C, Bernard F, Noel N, Alric L, Mirault T, Cohen F, Boussouar S, Resche-Rigon M, Cacoub P, Saadoun D. Desbois AC, et al. Among authors: perard l. Clin Immunol. 2018 Dec;197:54-59. doi: 10.1016/j.clim.2018.08.004. Epub 2018 Aug 18. Clin Immunol. 2018. PMID: 30125675
86 results